Allison Rosenthal

1.8k total citations
121 papers, 822 citations indexed

About

Allison Rosenthal is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Allison Rosenthal has authored 121 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 65 papers in Pathology and Forensic Medicine and 27 papers in Genetics. Recurrent topics in Allison Rosenthal's work include Lymphoma Diagnosis and Treatment (63 papers), CAR-T cell therapy research (38 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Allison Rosenthal is often cited by papers focused on Lymphoma Diagnosis and Treatment (63 papers), CAR-T cell therapy research (38 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Allison Rosenthal collaborates with scholars based in United States, Canada and Spain. Allison Rosenthal's co-authors include Anas Younes, Ruben A. Mesa, Courtney M. Wheatley, Dennis A. Gastineau, Lisa M. Rimsza, Richard J. Simpson, Bruce D. Johnson, Michael P. Gustafson, Emmanuel Katsanis and Zhaohui Jin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Allison Rosenthal

107 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allison Rosenthal United States	14	489	337	154	151	123	121	822
Jennifer L. Kelly United States	17	434 0.9×	639 1.9×	116 0.8×	279 1.8×	56 0.5×	40	1.0k
Jochen Heymanns Germany	20	311 0.6×	240 0.7×	114 0.7×	257 1.7×	135 1.1×	63	994
Kirsten Herbert Australia	14	210 0.4×	251 0.7×	82 0.5×	154 1.0×	271 2.2×	26	684
Silvia Franceschetti Italy	17	366 0.7×	751 2.2×	180 1.2×	422 2.8×	112 0.9×	47	1.3k
Clíona Grant United States	14	624 1.3×	763 2.3×	295 1.9×	280 1.9×	58 0.5×	42	1.3k
Paul Greaves United Kingdom	10	384 0.8×	309 0.9×	50 0.3×	151 1.0×	56 0.5×	24	731
John Amess United Kingdom	12	445 0.9×	619 1.8×	246 1.6×	358 2.4×	372 3.0×	16	1.3k
Isabelle Fleury Canada	12	235 0.5×	232 0.7×	71 0.5×	121 0.8×	36 0.3×	47	495
Lisa Argnani Italy	21	537 1.1×	948 2.8×	127 0.8×	298 2.0×	79 0.6×	120	1.4k
Cécile Borel France	13	170 0.3×	130 0.4×	74 0.5×	101 0.7×	270 2.2×	48	580

Countries citing papers authored by Allison Rosenthal

Since Specialization

Citations

This map shows the geographic impact of Allison Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Rosenthal more than expected).

Fields of papers citing papers by Allison Rosenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Rosenthal. The network helps show where Allison Rosenthal may publish in the future.

Co-authorship network of co-authors of Allison Rosenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Rosenthal. A scholar is included among the top collaborators of Allison Rosenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Rosenthal. Allison Rosenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boddicker, Nicholas, Raphael Mwangi, Dennis P. Robinson, et al.. (2025). Risk of lymphoid malignancy associated with cancer predisposition genes. Blood Cancer Journal. 15(1). 71–71.

Wright, George W., Hongli Li, James R. Cerhan, et al.. (2025). Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma. Blood Advances. 9(24). 6443–6454.

Tun, Aung M., Yucai Wang, Seth Maliske, et al.. (2024). Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy. Haematologica. 109(7). 2186–2195. 4 indexed citations

Mangold, Aaron R., William G. Breen, Allison Rosenthal, et al.. (2024). Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma: A Comparative Analysis of Regimens. Advances in Radiation Oncology. 9(7). 101502–101502. 1 indexed citations

Abbasi, Muhannad, Yi Lin, Jonas Paludo, et al.. (2024). Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies. Cardio-Oncology. 10(1). 91–91. 2 indexed citations

Tun, Aung M., Yucai Wang, Seth Maliske, et al.. (2024). Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy. Transplantation and Cellular Therapy. 30(10). 1001.e1–1001.e12. 1 indexed citations

Tun, Aung M., Romil Patel, Alex Niu, et al.. (2024). Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study. American Journal of Hematology. 99(9). 1712–1720. 4 indexed citations

Nastoupil, Loretta J., Manali Kamdar, Julio C. Chávez, et al.. (2023). LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE. Hematological Oncology. 41(S2). 212–214.

Butterfield, Richard, Collin M. Costello, William G. Rule, et al.. (2023). Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma. SHILAP Revista de lepidopterología. 2(4). 872–881. 1 indexed citations

10.

Huntington, Scott F., Stephen J. Schuster, Wei Ding, et al.. (2023). DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study. American Journal of Hematology. 98(5). 739–749. 7 indexed citations

11.

Saifi, Omran, Scott C. Lester, William G. Breen, et al.. (2023). Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach. American Journal of Hematology. 99(1). 124–134. 9 indexed citations

12.

Butterfield, Richard, Collin M. Costello, William G. Rule, et al.. (2023). Primary cutaneous diffuse large B-cell lymphoma, leg type, presenting as subcutaneous nodules: Case series and comparison of treatment outcomes. JAAD Case Reports. 41. 81–84. 1 indexed citations

13.

García-Robledo, Juan Esteban, Cristina Valencia-Sánchez, Brent P. Goodman, et al.. (2022). It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy. SHILAP Revista de lepidopterología. 15(1). 1–8.

14.

Moustafa, Muhamad Alhaj, Liuyan Jiang, Madiha Iqbal, et al.. (2022). Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience. Clinical Lymphoma Myeloma & Leukemia. 22(8). e815–e825. 2 indexed citations

15.

Chohan, Karan, Jason R. Young, Scott C. Lester, et al.. (2022). A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood Advances. 6(14). 4241–4250. 3 indexed citations

16.

Iqbal, Madiha, Radhika Bansal, Allison Rosenthal, et al.. (2022). Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 28(10). 668.e1–668.e6. 5 indexed citations

17.

Ensign, Shannon P. Fortin, Michael W. Ruff, Januario E. Castro, et al.. (2022). Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy. Current Treatment Options in Oncology. 23(12). 1845–1860. 6 indexed citations

18.

Iqbal, Madiha, Jonas Paludo, Allison Rosenthal, et al.. (2021). Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(2). e89–e95. 2 indexed citations

19.

Rahman, Zaid Abdel, et al.. (2021). Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell Lymphoma ☆. Hematology/Oncology and Stem Cell Therapy. 16(2). 133–143. 7 indexed citations

20.

Hilal, Talal, Zhen Wang, Diana Almader‐Douglas, et al.. (2018). Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta‐analysis. American Journal of Hematology. 93(10). 1220–1226. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact